In patients with advanced ovarian cancer, serum IL-6 levels were inversely correlated with Hb levels, and high serum IL-6 levels were attributed to M1 tumor-associated macrophages from the tumor microenvironment [35]. This evidence concerns the gene GSTM1 and neoplasm.